{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "adds_modification",
    "modifications" : [ {
      "modification_type" : "sumoylation"
    } ],
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ04867",
      "entity_text" : "PML-RARalpha",
      "entity_type" : "protein"
    },
    "is_direct" : true,
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P78317",
      "entity_text" : "RNF4",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The degradation of poly-SUMOylated PML-RARalpha by RNF4 forms the basis for the therapy of APL in response to arsenic trioxide [XREF_BIBR - XREF_BIBR, XREF_BIBR, XREF_BIBR].",
  "reading_complete" : "2020-08-08T15:02:34Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T14:58:21Z",
  "evidence" : [ "poly-SUMOylated PML-RARalpha by RNF4" ],
  "pmc_id" : "3901395",
  "score" : 0
}